A.R.T. Advisors, LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 48 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2016$117,000
-55.5%
48,803
-2.1%
0.01%
-50.0%
Q3 2015$263,000
+4.4%
49,848
+77.0%
0.01%
+25.0%
Q2 2015$252,000
+17.8%
28,160
-16.9%
0.01%
+14.3%
Q1 2015$214,000
+14.4%
33,896
+5.8%
0.01%0.0%
Q4 2014$187,00032,0250.01%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2016
NameSharesValueWeighting ↓
Opaleye Management Inc. 565,000$4,334,0001.81%
Ghost Tree Capital, LLC 350,000$2,685,0001.10%
Avoro Capital Advisors LLC 340,300$2,610,0000.90%
PURA VIDA INVESTMENTS, LLC 217,900$1,671,0000.70%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,467,858$11,258,0000.55%
Broadfin Capital, LLC 890,748$6,832,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,315,551$10,090,0000.41%
Lombard Odier Asset Management (USA) Corp 348,641$2,674,0000.26%
TURNER INVESTMENTS LLC 122,000$936,0000.19%
Integre Asset Management, LLC 64,317$493,0000.12%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders